The Effects of MHealth Interventions on Quality of Life, Anxiety, and Depression in Patients With Coronary Heart Disease: Meta-Analysis of Randomized Controlled Trials

Overview

Journal J Med Internet Res

Publisher JMIR Publications

Specialty Medical Informatics

Date 2024 Jun 11

PMID 38861710

Authors

Qiao Ling Hou

Le Yang Liu

Ying Wu

Affiliations

Soon will be listed here.

Abstract

Background: Coronary heart disease (CHD) is the leading cause of death globally. In addition, 20% to 40% of the patients with CHD have comorbid mental health issues such as anxiety or depression, affecting the prognosis and quality of life (QoL). Mobile health (mHealth) interventions have been developed and are widely used; however, the evidence for the effects of mHealth interventions on QoL, anxiety, and depression in patients with CHD is currently ambiguous.

Objective: In this study, we aimed to assess the effects of mHealth interventions on QoL, anxiety, and depression in patients with CHD.

Methods: We searched the Cochrane Library, PubMed, Embase, CINAHL, Web of Science, China National Knowledge Infrastructure, and Wanfang databases from inception to August 12, 2023. Eligible studies were randomized controlled trials that involved patients with CHD who received mHealth interventions and that reported on QoL, anxiety, or depression outcomes. We used the Cochrane risk-of-bias tool for randomized trials to evaluate the risk of bias in the studies, ensuring a rigorous and methodologically sound analysis. Review Manager (desktop version 5.4; The Cochrane Collaboration) and Stata MP (version 17.0; StataCorp LLC) were used to conduct the meta-analysis. The effect size was calculated using the standardized mean difference (SMD) and its 95% CI.

Results: The meta-analysis included 23 studies (5406 participants in total) and showed that mHealth interventions significantly improved QoL in patients with CHD (SMD 0.49, 95% CI 0.25-0.72; Z=4.07; P<.001) as well as relieved their anxiety (SMD -0.46, 95% CI -0.83 to -0.08; Z=2.38; P=.02) and depression (SMD -0.34, 95% CI -0.56 to -0.12; Z=3.00; P=.003) compared to usual care. The subgroup analyses indicated a significant effect favoring the mHealth intervention on reducing anxiety and depressive symptoms compared to usual care, especially when (1) the intervention duration was ≥6 months (P=.04 and P=.001), (2) the mHealth intervention was a simple one (only 1 mHealth intervention was used) (P=.01 and P<.001), (3) it was implemented during the COVID-19 pandemic (P=.04 and P=.01), (4) it was implemented in low- or middle-income countries (P=.01 and P=.02), (5) the intervention focused on mental health (P=.01 and P=.007), and (6) adherence rates were high (≥90%; P=.03 and P=.002). In addition, comparing mHealth interventions to usual care, there was an improvement in QoL when (1) the mHealth intervention was a simple one (P<.001), (2) it was implemented in low- or middle-income countries (P<.001), and (3) the intervention focused on mental health (P<.001).

Conclusions: On the basis of the existing evidence, mHealth interventions might be effective in improving QoL and reducing anxiety and depression in patients with CHD. However, large sample, high-quality, and rigorously designed randomized controlled trials are needed to provide further evidence.

Trial Registration: PROSPERO CRD42022383858; https://tinyurl.com/3ea2npxf.

References

Batalik L, Filakova K, Sladeckova M, Dosbaba F, Su J, Pepera G . The cost-effectiveness of exercise-based cardiac telerehabilitation intervention: a systematic review. Eur J Phys Rehabil Med. 2023; 59(2):248-258. PMC: 10167703. DOI: 10.23736/S1973-9087.23.07773-0. View

Snoek J, Meindersma E, Prins L, Vant Hof A, de Boer M, Hopman M . The sustained effects of extending cardiac rehabilitation with a six-month telemonitoring and telecoaching programme on fitness, quality of life, cardiovascular risk factors and care utilisation in CAD patients: The TeleCaRe study. J Telemed Telecare. 2019; 27(8):473-483. DOI: 10.1177/1357633X19885793. View

Lichtman J, Froelicher E, Blumenthal J, Carney R, Doering L, Frasure-Smith N . Depression as a risk factor for poor prognosis among patients with acute coronary syndrome: systematic review and recommendations: a scientific statement from the American Heart Association. Circulation. 2014; 129(12):1350-69. DOI: 10.1161/CIR.0000000000000019. View

Whittaker R, McRobbie H, Bullen C, Rodgers A, Gu Y . Mobile phone-based interventions for smoking cessation. Cochrane Database Syst Rev. 2016; 4:CD006611. PMC: 6485940. DOI: 10.1002/14651858.CD006611.pub4. View

Cosh S, Pinto R, Denson L, Tully P . Understandings and experiences of adherence to secondary prevention for patients with cardiovascular disease and comorbid depression or anxiety. Psychol Health Med. 2022; 28(6):1479-1486. DOI: 10.1080/13548506.2022.2060515. View

Kraal J, Elske van den Akker-van Marle M, Abu-Hanna A, Stut W, Peek N, Kemps H . Clinical and cost-effectiveness of home-based cardiac rehabilitation compared to conventional, centre-based cardiac rehabilitation: Results of the FIT@Home study. Eur J Prev Cardiol. 2017; 24(12):1260-1273. PMC: 5518918. DOI: 10.1177/2047487317710803. View

Park Y . Emerging New Era of Mobile Health Technologies. Healthc Inform Res. 2016; 22(4):253-254. PMC: 5116535. DOI: 10.4258/hir.2016.22.4.253. View

Ellingson L, Lansing J, Deshaw K, Peyer K, Bai Y, Perez M . Evaluating Motivational Interviewing and Habit Formation to Enhance the Effect of Activity Trackers on Healthy Adults' Activity Levels: Randomized Intervention. JMIR Mhealth Uhealth. 2019; 7(2):e10988. PMC: 6393778. DOI: 10.2196/10988. View

Klimis H, Marschner S, von Huben A, Thiagalingam A, Chow C . Predictors of Smoking Cessation in a Lifestyle-Focused Text-Message Support Programme Delivered to People with Coronary Heart Disease: An Analysis From the Tobacco Exercise and Diet Messages (TEXTME) Randomised Clinical Trial. Tob Use Insights. 2020; 13:1179173X20901486. PMC: 6987487. DOI: 10.1177/1179173X20901486. View

10.

Peter R, Meyer M, Mons U, Schottker B, Keller F, Schmucker R . Long-term trajectories of anxiety and depression in patients with stable coronary heart disease and risk of subsequent cardiovascular events. Depress Anxiety. 2020; 37(8):784-792. DOI: 10.1002/da.23011. View

11.

Johnston N, Bodegard J, Jerstrom S, Akesson J, Brorsson H, Alfredsson J . Effects of interactive patient smartphone support app on drug adherence and lifestyle changes in myocardial infarction patients: A randomized study. Am Heart J. 2016; 178:85-94. DOI: 10.1016/j.ahj.2016.05.005. View

12.

Subedi N, Rawstorn J, Gao L, Koorts H, Maddison R . Implementation of Telerehabilitation Interventions for the Self-Management of Cardiovascular Disease: Systematic Review. JMIR Mhealth Uhealth. 2020; 8(11):e17957. PMC: 7732711. DOI: 10.2196/17957. View

13.

Visseren F, Mach F, Smulders Y, Carballo D, Koskinas K, Back M . 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J. 2021; 42(34):3227-3337. DOI: 10.1093/eurheartj/ehab484. View

14.

Kang S, Baek H, Cho J, Kim S, Hwang H, Lee W . Management of cardiovascular disease using an mHealth tool: a randomized clinical trial. NPJ Digit Med. 2021; 4(1):165. PMC: 8642390. DOI: 10.1038/s41746-021-00535-z. View

15.

Garcia-Lunar I, van der Ploeg H, Fernandez Alvira J, van Nassau F, Castellano Vazquez J, van der Beek A . Effects of a comprehensive lifestyle intervention on cardiovascular health: the TANSNIP-PESA trial. Eur Heart J. 2022; 43(38):3732-3745. PMC: 9553098. DOI: 10.1093/eurheartj/ehac378. View

16.

Zhao M, Graham I, Cooney M, Grobbee D, Vaartjes I, Klipstein-Grobusch K . Determinants of coronary artery disease risk factor management across three world regions. Heart Asia. 2019; 11(1):e011112. PMC: 6454324. DOI: 10.1136/heartasia-2018-011112. View

17.

Widmer R, Allison T, Lennon R, Lopez-Jimenez F, Lerman L, Lerman A . Digital health intervention during cardiac rehabilitation: A randomized controlled trial. Am Heart J. 2017; 188:65-72. DOI: 10.1016/j.ahj.2017.02.016. View

18.

Islam S, Chow C, Redfern J, Kok C, Radholm K, Stepien S . Effect of text messaging on depression in patients with coronary heart disease: a substudy analysis from the TEXT ME randomised controlled trial. BMJ Open. 2019; 9(2):e022637. PMC: 6398727. DOI: 10.1136/bmjopen-2018-022637. View

19.

Hershman S, Bot B, Shcherbina A, Doerr M, Moayedi Y, Pavlovic A . Physical activity, sleep and cardiovascular health data for 50,000 individuals from the MyHeart Counts Study. Sci Data. 2019; 6(1):24. PMC: 6472350. DOI: 10.1038/s41597-019-0016-7. View

20.

Xia K, Wang L, Yang X, Jiang H, Zhang L, Yao D . Comparing the effects of depression, anxiety, and comorbidity on quality-of-life, adverse outcomes, and medical expenditure in Chinese patients with acute coronary syndrome. Chin Med J (Engl). 2019; 132(9):1045-1052. PMC: 6595882. DOI: 10.1097/CM9.0000000000000215. View